131 related articles for article (PubMed ID: 20621376)
21. Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women.
Tsiotra PC; Tsigos C; Yfanti E; Anastasiou E; Vikentiou M; Psarra K; Papasteriades C; Raptis SA
Horm Metab Res; 2007 Oct; 39(10):758-63. PubMed ID: 17952840
[TBL] [Abstract][Full Text] [Related]
22. Visfatin response to glucose is reduced in women with gestational diabetes mellitus.
Haider DG; Handisurya A; Storka A; Vojtassakova E; Luger A; Pacini G; Tura A; Wolzt M; Kautzky-Willer A
Diabetes Care; 2007 Jul; 30(7):1889-91. PubMed ID: 17416788
[No Abstract] [Full Text] [Related]
23. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.
Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T
Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892
[TBL] [Abstract][Full Text] [Related]
24. Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise.
Frydelund-Larsen L; Akerstrom T; Nielsen S; Keller P; Keller C; Pedersen BK
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E24-31. PubMed ID: 16868228
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
26. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus.
Chan TF; Chen YL; Lee CH; Chou FH; Wu LC; Jong SB; Tsai EM
J Soc Gynecol Investig; 2006 Jul; 13(5):364-7. PubMed ID: 16814166
[TBL] [Abstract][Full Text] [Related]
27. Visfatin expression is not associated with adipose tissue abundance in the porcine model.
Palin MF; Labrecque B; Beaudry D; Mayhue M; Bordignon V; Murphy BD
Domest Anim Endocrinol; 2008 Jul; 35(1):58-73. PubMed ID: 18343625
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of adiponectin and TNFalpha genes expression in women with gestational diabetes. Preliminary results].
Kuźmicki M; Szamatowicz J; Kretowski A; Kuć P; Kretowski M; Wawrusiewicz N; Okruszko A; Leroith D; Górska M
Ginekol Pol; 2006 Dec; 77(12):930-6. PubMed ID: 17373119
[TBL] [Abstract][Full Text] [Related]
29. The role of visfatin in pathogenesis of gestational diabetes (GDM).
Radzicka S; Pietryga M; Iciek R; Brązert J
Ginekol Pol; 2018; 89(9):518-521. PubMed ID: 30318580
[TBL] [Abstract][Full Text] [Related]
30. Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes.
Chen D; Xia G; Xu P; Dong M
Acta Obstet Gynecol Scand; 2010 Dec; 89(12):1595-9. PubMed ID: 20822472
[TBL] [Abstract][Full Text] [Related]
31. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
32. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
[TBL] [Abstract][Full Text] [Related]
33. Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth.
Bienertová-Vašků J; Bienert P; Zlámal F; Tomandl J; Tomandlová M; Dostálová Z; Vašků A
Diabetes Res Clin Pract; 2012 Jun; 96(3):355-61. PubMed ID: 21741723
[TBL] [Abstract][Full Text] [Related]
34. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus.
Uzelac PS; Li X; Lin J; Neese LD; Lin L; Nakajima ST; Bohler H; Lei Z
Placenta; 2010 Jul; 31(7):581-8. PubMed ID: 20421132
[TBL] [Abstract][Full Text] [Related]
36. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
[TBL] [Abstract][Full Text] [Related]
37. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.
Colomiere M; Permezel M; Lappas M
J Mol Endocrinol; 2010 Apr; 44(4):213-23. PubMed ID: 19955252
[TBL] [Abstract][Full Text] [Related]
38. The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes.
Kuzmicki M; Telejko B; Wawrusiewicz-Kurylonek N; Citko A; Lipinska D; Pliszka J; Wilk J; Kalejta K; Lemancewicz A; Grabiec M; Pryszczepko-Wawreszuk AM; Skibicka J; Kretowski A; Gorska M; Szamatowicz J
Gynecol Endocrinol; 2012 Nov; 28(11):841-4. PubMed ID: 22587677
[TBL] [Abstract][Full Text] [Related]
39. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects.
Johansson LM; Johansson LE; Ridderstråle M
Metabolism; 2008 Nov; 57(11):1558-62. PubMed ID: 18940394
[TBL] [Abstract][Full Text] [Related]
40. Altered perlecan expression in placental development and gestational diabetes mellitus.
Yang WC; Su TH; Yang YC; Chang SC; Chen CY; Chen CP
Placenta; 2005 Nov; 26(10):780-8. PubMed ID: 16226129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
